| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $97.9M | — |
| R&D Expense | $246K | +378.1% |
| SG&A Expense | $7.3M | -18.7% |
| Operating Income | -$11.8M | +21.4% |
| Pre-tax Income | -$13.1M | +42.0% |
| Income Tax | $0 | — |
| Net Income | -$15.0M | +33.7% |
| EPS (Basic) | -$0.73 | +80.9% |
| EPS (Diluted) | -$0.73 | +80.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $343K | +141.1% |
| Accounts Receivable | $1.3M | +4032.9% |
| Current Assets | $2.0M | -38.0% |
| Total Assets | $13.2M | +89.5% |
| Current Liabilities | $5.2M | +18.9% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $5.2M | +18.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.6M | -11.5% |
| Investing Cash Flow | -$400K | -122.7% |
| Financing Cash Flow | $2.6M | -32.2% |
| $8.0M |
| +209.1% |